7-Hydroxy-4-methylcoumarin [4-Methylumbelliferone] *Fluorescence reference standard*
7-羟基-4-甲基香豆素*荧光参照标准*
货号: 41 品牌: AAT Bioquest 标签: 有机试剂
规格信息
品牌: |
AAT Bioquest |
---|---|
CAS: |
90-33-5 |
规格: |
1 g |
货期: |
5-7天(参考) |
7-Hydroxy-4-methylcoumarin [4-Methylumbelliferone] *Fluorescence reference standard*
7-羟基-4-甲基香豆素*荧光参照标准*
货号: 41 品牌: AAT Bioquest 标签: 有机试剂
品牌: |
AAT Bioquest |
---|---|
CAS: |
90-33-5 |
规格: |
1 g |
货期: |
5-7天(参考) |
384孔 2D储存管盖,配套圆形管,袋装,384个/包, 100包/箱, 38400个帽/箱 货号: 8511 品牌: 康宁Corning 标签: 条码冻存管
品牌: |
康宁Corning |
---|---|
CAS: |
N/A |
规格: |
384个/包, 100包/箱384个/包, 100包/箱 |
货期: |
2-3天 |
名称 | MDA-MB-231(人乳腺癌细胞)(L15) (STR鉴定正确) |
别称 | MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA231; MB231; MD Anderson-Metastatic Breast-231 |
背景描述 | MDA-MB-231来自患有转移乳腺腺癌的51岁女病人的胸水。 在裸鼠和ALS处理的BALB/c小鼠中,它能形成低分化腺癌(III级)。细胞表达WNT7B癌基因。 |
种属 | 人类 |
年龄(性别) | 女性,51岁 |
组织来源 | 乳腺腺癌,转移性胸膜渗出液 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 乳腺癌细胞 |
生物安全等级 | 1 |
生长培养基 | Leibovitz’s L-15+10% FBS+1% P/S |
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2~3次/周 |
倍增时间 | ~32-42小时 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养条件 | 气相:空气,100% 温度:37℃ |
致瘤性 | Yes, in ALS treated BALB/c mice, forms poorly differentiated adenocarcinoma (grade III).Yes, in nude mice, forms poorly differentiated adenocarcinoma (grade III). |
受体表达情况 | epidermal growth factor (EGF), expressed;transforming growth factor alpha (TGF alpha), expressed |
注意事项 | 1、该细胞推荐使用Leibovitz’s L-15培养基进行培养,Leibovitz’s L-15不可以通入二氧化碳,会产生细胞毒性; 2、如您没有无二氧化碳的培养箱,可使用DMEM替代Leibovitz’s L-15,使用DMEM培养基时即可正常通入5%二氧化碳; 3、配套专用培养基默认Leibovitz’s L-15配置,如需DMEM配方,请联系销售下单备注更改。 |
保藏机构 | ATCC; CRL-12532ATCC; HTB-26 ATCC; CRM-HTB-26 BCRC; 60425 BCRJ; 0164 DSMZ; ACC-732 ECACC; 92020424 |
Amelogenin | X,X |
CSF1PO | 12,13 |
D2S1338 | 20,21 |
D3S1358 | 16,16 |
D5S818 | 12,12 |
D7S820 | 8,9 |
D8S1179 | 13,13 |
D13S317 | 13,13 |
D16S539 | 12,12 |
D18S51 | 11,16 |
D19S433 | 11,14 |
D21S11 | 33.2,33.2 |
FGA | 22,23 |
PentaD | 11,14 |
PentaE | 11,11 |
TH01 | 7,9.3 |
TPOX | 8,9 |
vWA | 15,18 |
D6S1043 | 18,18 |
D12S391 | 17,18 |
D2S441 | 14,15 |
Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase(2021/08/05)
作者:Ximing Shao, Zhihao Ding, Wenhua Zhou
期刊:Nature Nanotechnology
DOI:10.1038/s41565-021-00952-x
影响因子 :40.523
引用产品:CL-0016 CL-0101 CL-0103 CL-0150A CL-0150B CL-0236 CL-0238
Mitochondria-targeted magnetic gold nanoheterostructure for multi-modal imaging guided photothermal and photodynamic therapy of triple-negative breast cancer(2020/07/24)
作者:Bo Li, Qian Zhou, Haiyang Wang
期刊:Chemical Engineering Journal
DOI:10.1016/j.cej.2020.126364
影响因子 :16.744
引用产品:CL-0150A CL-0150B
MoS2 Quantum Dot@Polyaniline Inorganic–Organic Nanohybrids for in Vivo Dual-Modal Imaging Guided Synergistic Photothermal/Radiation Therapy(2016/09/07)
作者:Jinping Wang, Xiaoxiao Tan, Xiaojuan Pang
期刊:ACS Applied Materials & Interfaces
DOI:10.1021/acsami.6b08391
影响因子 :10.3830
引用产品:CL-0016 CL-0101 CL-0103 CL-0150A CL-0150B CL-0236 CL-0238
Phenotype-related drug sensitivity analysis of single CTCs for medicine evaluation(2020/08/10)
作者:Haimeng Pei, Mei Yu, Defang Dong
期刊:Chemical Science
DOI:10.1039/C9SC05566E
影响因子 :9.969
引用产品:CL-0149 CL-0150A CL-0150B
Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer(2021/4/19)
作者:Xinxing Wang, Bingjian Xue, Yujie Zhang
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03684-x
影响因子 :9.685
引用产品:CL-0040 CL-0041 CL-0149 CL-0150A CL-0150B CL-0152A CL-0152B CL-0290A CL-0290B CL-0525
MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis(2021/04/06)
作者:Fengxia Chen, Qingqing Wang, Xiaoyan Yu
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03661-4
影响因子 :9.685
引用产品:CL-0005 CL-0041 CL-0114 CL-0150A CL-0150B CL-0380 CL-0525 PM150312B
Simultaneous Fluorescence Visualization of Epithelial-Mesenchymal Transition and Apoptosis Processes in Tumor Cells for Evaluating the Impact of Epithelial-Mesenchymal Transition on Drug Efficacy(2018/09/18)
作者:Mingming Luan, Jinjie Chang, Wei Pan
期刊:Anal Chem
DOI:10.1021/acs.analchem.8b02494
影响因子 :8.008
引用产品:CL-0150A CL-0150B CL-0184 CL-0525
A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer(2019/11/08)
作者:Lairong Ding, Junwei Li, Changrong Wu
期刊:Journal of Materials Chemistry B
DOI:10.1039/C9TB01610D
影响因子 :7.571
引用产品:CL-0150A CL-0150B
Assessment of 2-allyl-4,5-dimethoxyphenol safety and attractiveness to mature males of Bactrocera dorsalis (Hendel)(2021/08/04)
作者:Shuzhen Deng, Xinyang Li, Ziming Wang
期刊:Ecotoxicology And Environmental Safety
DOI:10.1016/j.ecoenv.2021.112567
影响因子 :7.129
引用产品:CL-0037 CL-0106 CL-0150A CL-0150B
A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy(2021/03/23)
作者:Hairong Wang, Yawen Zhang, Xiangle Zeng
期刊:International Journal of Nanomedicine
DOI:10.2147/IJN.S299681
影响因子 :7.0330
引用产品:CL-0149 CL-0150A CL-0150B
Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer(2020/04/21)
作者:Peng Xu, Jia Yao, Zhen Li
期刊:International Journal of Nanomedicine
DOI:10.2147/IJN.S243037
影响因子 :7.0330
引用产品:CL-0150A CL-0150B
Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer(2019/06/21)
作者:Jianing Tang, Qian Yang, Qiuxia Cui
期刊:Journal Of Cellular Physiology
DOI:10.1002/jcp.28980
影响因子 :6.513
引用产品:CL-0150A CL-0150B
Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer(2020/01/05)
作者:Huan Tang, Jinglin Chen, Lin Wang
期刊:International Journal of Pharmaceutics
DOI:10.1016/j.ijpharm.2019.118806
影响因子 :6.510
引用产品:CL-0150A CL-0150B
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis(2021/07/19)
作者:Mingzhi Zhu, Yanyan Wang, Fang Wang
期刊:Cancer Cell International
DOI:10.1186/s12935-021-02088-3
影响因子 :6.429
引用产品:CL-0150A CL-0150B CL-0152A CL-0152B CL-0525
Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway(2019/10/07)
作者:Tianqi Li, Yudi Xiong, Qingqing Wang
期刊:Artificial Cells Nanomedicine and Biotechnology
DOI:10.1080/21691401.2019.1670670
影响因子 :6.355
引用产品:CL-0150A CL-0150B CL-0525
UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway(2021/10/20)
作者:Zinan Lu, Jia Song, Tonghui Sun
期刊:Chinese Medical Journal
DOI:10.1097/CM9.0000000000001708
影响因子 :6.1330
引用产品:CL-0149 CL-0150A
Enzymatic rhamnosylation of anticancer drugs by an α-l-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy(2019/08/08)
作者:Li Xu , Xiaohong Liu , Yinping Li
期刊:Applied Microbiology And Biotechnology
DOI:10.1007/s00253-019-10011-0
影响因子 :5.560
引用产品:CL-0150A CL-0150B CL-0525
Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer(2021/10/29)
作者:Wenqing Tang, Fangshi Xu, Meng Zhao
期刊:Bmc Cancer
DOI:10.1186/s12885-021-08892-4
影响因子 :4.638
引用产品:CL-0149 CL-0150A CL-0150B CL-0525
Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6(2020/06/11)
作者:Meng Jin, Daili Gao, Rongchun Wang
期刊:Oncology Reports
DOI:10.3892/or.2020.7644
影响因子 :4.136
引用产品:CL-0149 CL-0150A CL-0150B
Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell(2019/08/14)
作者:Mingjiang Yao, Xiaodi Fan, Bo Yuan
期刊:BMC Complementary and Alternative Medicine volume
DOI:10.1186/s12906-019-2615-4
影响因子 :3.6590
引用产品:CL-0150A CL-0150B
The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells(2019/09/22)
作者:Yue Yang, Pingya He
期刊:Evidence-Based Complementary and Alternative Medicine
DOI:10.1155/2019/1242784
影响因子 :2.650
引用产品:CL-0150A CL-0150B CL-0215
3-Cyano-7-hydroxycoumarin *CAS 19088-73-4*
3-氰基-7-羟基香豆素*荧光参照标准*
货号: 40 品牌: AAT Bioquest 标签: 有机试剂
品牌: |
AAT Bioquest |
---|---|
CAS: |
19088-73-4 |
规格: |
25 mg |
货期: |
5-7天(参考) |
名称 | MDA-MB-231(人乳腺癌细胞)(DMEM) (STR鉴定正确) |
别称 | MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA231; MB231; MD Anderson-Metastatic Breast-231 |
背景描述 | MDA-MB-231来自患有转移乳腺腺癌的51岁女病人的胸水。 在裸鼠和ALS处理的BALB/c小鼠中,它能形成低分化腺癌(III级)。细胞表达WNT7B癌基因。 |
种属 | 人类 |
年龄(性别) | 女性,51岁 |
组织来源 | 乳腺腺癌,转移性胸膜渗出液 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 乳腺癌细胞 |
生物安全等级 | 1 |
生长培养基 | DMEM+10% FBS+1% P/S |
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2~3次/周 |
倍增时间 | ~32-42小时 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养条件 | 气相:空气,95%;CO2,5% 温度:37℃ |
致瘤性 | Yes, in ALS treated BALB/c mice, forms poorly differentiated adenocarcinoma (grade III).Yes, in nude mice, forms poorly differentiated adenocarcinoma (grade III). |
受体表达情况 | epidermal growth factor (EGF), expressed;transforming growth factor alpha (TGF alpha), expressed |
保藏机构 | ATCC; CRL-12532ATCC; HTB-26 ATCC; CRM-HTB-26 BCRC; 60425 BCRJ; 0164 DSMZ; ACC-732 ECACC; 92020424 |
Amelogenin | X,X |
CSF1PO | 12,13 |
D2S1338 | 20,21 |
D3S1358 | 16,16 |
D5S818 | 12,12 |
D7S820 | 8,9 |
D8S1179 | 13,13 |
D13S317 | 13,13 |
D16S539 | 12,12 |
D18S51 | 11,16 |
D19S433 | 11,14 |
D21S11 | 33.2,33.2 |
FGA | 22,23 |
PentaD | 11,14 |
PentaE | 11,11 |
TH01 | 7,9.3 |
TPOX | 8,9 |
vWA | 15,18 |
D6S1043 | 18,18 |
D12S391 | 17,18 |
D2S441 | 14,15 |
Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase(2021/08/05)
作者:Ximing Shao, Zhihao Ding, Wenhua Zhou
期刊:Nature Nanotechnology
DOI:10.1038/s41565-021-00952-x
影响因子 :40.523
引用产品:CL-0016 CL-0101 CL-0103 CL-0150A CL-0150B CL-0236 CL-0238
Mitochondria-targeted magnetic gold nanoheterostructure for multi-modal imaging guided photothermal and photodynamic therapy of triple-negative breast cancer(2020/07/24)
作者:Bo Li, Qian Zhou, Haiyang Wang
期刊:Chemical Engineering Journal
DOI:10.1016/j.cej.2020.126364
影响因子 :16.744
引用产品:CL-0150A CL-0150B
MoS2 Quantum Dot@Polyaniline Inorganic–Organic Nanohybrids for in Vivo Dual-Modal Imaging Guided Synergistic Photothermal/Radiation Therapy(2016/09/07)
作者:Jinping Wang, Xiaoxiao Tan, Xiaojuan Pang
期刊:ACS Applied Materials & Interfaces
DOI:10.1021/acsami.6b08391
影响因子 :10.3830
引用产品:CL-0016 CL-0101 CL-0103 CL-0150A CL-0150B CL-0236 CL-0238
Phenotype-related drug sensitivity analysis of single CTCs for medicine evaluation(2020/08/10)
作者:Haimeng Pei, Mei Yu, Defang Dong
期刊:Chemical Science
DOI:10.1039/C9SC05566E
影响因子 :9.969
引用产品:CL-0149 CL-0150A CL-0150B
Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer(2021/4/19)
作者:Xinxing Wang, Bingjian Xue, Yujie Zhang
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03684-x
影响因子 :9.685
引用产品:CL-0040 CL-0041 CL-0149 CL-0150A CL-0150B CL-0152A CL-0152B CL-0290A CL-0290B CL-0525
MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis(2021/04/06)
作者:Fengxia Chen, Qingqing Wang, Xiaoyan Yu
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03661-4
影响因子 :9.685
引用产品:CL-0005 CL-0041 CL-0114 CL-0150A CL-0150B CL-0380 CL-0525 PM150312B
Simultaneous Fluorescence Visualization of Epithelial-Mesenchymal Transition and Apoptosis Processes in Tumor Cells for Evaluating the Impact of Epithelial-Mesenchymal Transition on Drug Efficacy(2018/09/18)
作者:Mingming Luan, Jinjie Chang, Wei Pan
期刊:Anal Chem
DOI:10.1021/acs.analchem.8b02494
影响因子 :8.008
引用产品:CL-0150A CL-0150B CL-0184 CL-0525
A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer(2019/11/08)
作者:Lairong Ding, Junwei Li, Changrong Wu
期刊:Journal of Materials Chemistry B
DOI:10.1039/C9TB01610D
影响因子 :7.571
引用产品:CL-0150A CL-0150B
Assessment of 2-allyl-4,5-dimethoxyphenol safety and attractiveness to mature males of Bactrocera dorsalis (Hendel)(2021/08/04)
作者:Shuzhen Deng, Xinyang Li, Ziming Wang
期刊:Ecotoxicology And Environmental Safety
DOI:10.1016/j.ecoenv.2021.112567
影响因子 :7.129
引用产品:CL-0037 CL-0106 CL-0150A CL-0150B
A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy(2021/03/23)
作者:Hairong Wang, Yawen Zhang, Xiangle Zeng
期刊:International Journal of Nanomedicine
DOI:10.2147/IJN.S299681
影响因子 :7.0330
引用产品:CL-0149 CL-0150A CL-0150B
Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer(2020/04/21)
作者:Peng Xu, Jia Yao, Zhen Li
期刊:International Journal of Nanomedicine
DOI:10.2147/IJN.S243037
影响因子 :7.0330
引用产品:CL-0150A CL-0150B
Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer(2019/06/21)
作者:Jianing Tang, Qian Yang, Qiuxia Cui
期刊:Journal Of Cellular Physiology
DOI:10.1002/jcp.28980
影响因子 :6.513
引用产品:CL-0150A CL-0150B
Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer(2020/01/05)
作者:Huan Tang, Jinglin Chen, Lin Wang
期刊:International Journal of Pharmaceutics
DOI:10.1016/j.ijpharm.2019.118806
影响因子 :6.510
引用产品:CL-0150A CL-0150B
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis(2021/07/19)
作者:Mingzhi Zhu, Yanyan Wang, Fang Wang
期刊:Cancer Cell International
DOI:10.1186/s12935-021-02088-3
影响因子 :6.429
引用产品:CL-0150A CL-0150B CL-0152A CL-0152B CL-0525
Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway(2019/10/07)
作者:Tianqi Li, Yudi Xiong, Qingqing Wang
期刊:Artificial Cells Nanomedicine and Biotechnology
DOI:10.1080/21691401.2019.1670670
影响因子 :6.355
引用产品:CL-0150A CL-0150B CL-0525
Enzymatic rhamnosylation of anticancer drugs by an α-l-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy(2019/08/08)
作者:Li Xu , Xiaohong Liu , Yinping Li
期刊:Applied Microbiology And Biotechnology
DOI:10.1007/s00253-019-10011-0
影响因子 :5.560
引用产品:CL-0150A CL-0150B CL-0525
Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer(2021/10/29)
作者:Wenqing Tang, Fangshi Xu, Meng Zhao
期刊:Bmc Cancer
DOI:10.1186/s12885-021-08892-4
影响因子 :4.638
引用产品:CL-0149 CL-0150A CL-0150B CL-0525
Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6(2020/06/11)
作者:Meng Jin, Daili Gao, Rongchun Wang
期刊:Oncology Reports
DOI:10.3892/or.2020.7644
影响因子 :4.136
引用产品:CL-0149 CL-0150A CL-0150B
Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell(2019/08/14)
作者:Mingjiang Yao, Xiaodi Fan, Bo Yuan
期刊:BMC Complementary and Alternative Medicine volume
DOI:10.1186/s12906-019-2615-4
影响因子 :3.6590
引用产品:CL-0150A CL-0150B
Overexpression of HOXD8 inhibits the proliferation, migration and invasion of breast cancer cells by downregulating ILP2 expression(2021/7/15)
作者:Xiaoyun Wen,Yu Chen, Xiansong Fang
期刊:Experimental and Therapeutic Medicine
DOI:10.3892/etm.2021.10439
影响因子 :2.7510
引用产品:CL-0149 CL-0150B CL-0211 CL-0525
The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells(2019/09/22)
作者:Yue Yang, Pingya He
期刊:Evidence-Based Complementary and Alternative Medicine
DOI:10.1155/2019/1242784
影响因子 :2.650
引用产品:CL-0150A CL-0150B CL-0215